Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Interferons adverse reaction |
Causative agent |
True |
Interferon |
Inferred relationship |
Some |
1 |
bivirkning af humant interferon gamma-1b |
Causative agent |
False |
Interferon |
Inferred relationship |
Some |
|
Interferon-A-2a adverse reaction |
Causative agent |
False |
Interferon |
Inferred relationship |
Some |
|
Interferon-A-2b adverse reaction |
Causative agent |
False |
Interferon |
Inferred relationship |
Some |
|
Interferon-A-N1 adverse reaction |
Causative agent |
False |
Interferon |
Inferred relationship |
Some |
|
Interferon gamma assay |
Has measured component |
False |
Interferon |
Inferred relationship |
Some |
|
Interferon alpha assay |
Has measured component |
False |
Interferon |
Inferred relationship |
Some |
|
Interferon assay |
Has measured component |
False |
Interferon |
Inferred relationship |
Some |
|
Interferon beta assay |
Has measured component |
False |
Interferon |
Inferred relationship |
Some |
|
Interferon gamma assay |
Component |
False |
Interferon |
Inferred relationship |
Some |
|
Interferon alpha assay |
Component |
False |
Interferon |
Inferred relationship |
Some |
|
Interferon assay |
Component |
True |
Interferon |
Inferred relationship |
Some |
1 |
Interferon beta assay |
Component |
False |
Interferon |
Inferred relationship |
Some |
|
Product containing interferon beta-1a (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
Product containing interferon beta-1b (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
Product containing interferon alfa-2a (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
Product containing interferon alfa-2b (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfa-2b 10 MIE pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfa-2b 5 MIE pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfa-2b 3 MIE pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfa-2b 1 MIE pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfa-2b 6 MIE/ml injektionsvæske, opløsning, hætteglas a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfa-2a 18 MIE/ml injektionsvæske, opløsning, hætteglas a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon beta-1b 8 MIE pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfa-2a 6 MIE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfa-2a 9 MIE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfa-2a 12 MIE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfa-2a 18 MIE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon beta-1a 6 MIE pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfa-2b 15 MIE/1 ml fyldt pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfa-2b 25 MIE/1 ml fyldt pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfa-2b 50 MIE/1 ml fyldt pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfa-2b 10 MIE/ml injektionsvæske, opløsning, hætteglas a 2,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon beta-1a 12 MIE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon beta-1a 24 MIE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfa-2a 18 MIE/0,6 ml injektionsvæske, opløsning, cylinderampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
peginterferon alfa-2b 50 µg pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
peginterferon alfa-2b 80 µg pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
peginterferon alfa-2b 100 µg pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
peginterferon alfa-2b 150 µg pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
peginterferon alfa-2b 120 µg pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
Product containing peginterferon alfa-2b (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
Interferon alfa-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
Interferon beta-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfacon 130 µg/ml injektionsvæske, opløsning, cylinderampul a 0,3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon beta-1b 100 µg injektionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfa-2b 5 MIE/pulver, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfa-2b 25 MIE/pulver, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfa-2b 50 MIE/pulver, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfa-2b 10 MIE/hætteglas pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfa-2b 3 MIE/pulver, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfa-2b 18 MIE/pulver, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfa-2b 25 MIE/opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfa-2b 18 MIE/opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
Interferon alfa-2b 10 million iu/vial solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfa-2b 3 MIE/opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfa-2b 5 MIE/opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfa-2b 30 MIE opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfa-2b 60 MIE/IE opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfa-2b 150 µg pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfa-2b 300 µg pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfa-2b 120 µg pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfa-2b 600 µg pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfa-2b 100000 µg pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfa-2b 50 µg pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
Product containing peginterferon alfa-2a (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfa-n3 humant leu 5 MIE/ml injektionsvæske, opløsning, hætteglas a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfa-2a 6 MIE/injektionsvæske, opløsning, hætteglas a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfa-2a 9 MIE/injektionsvæske, opløsning, hætteglas a 0,9 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfa-2a 36 MIE/ml injektionsvæske, opløsning, hætteglas a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfa-2a 3 MIE/injektionsvæske, opløsning, hætteglas a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfa-2a 18 MIE/3 ml injektionsvæske, opløsning, hætteglas a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfa-2a 3 MIE/injektionsvæske, opløsning, fyldt sprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon beta-1a 30 µg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
Interferon alfa-2a 6miu/vial injection solution 0.5mL syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
PEG-intron redipen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
PEG-intron redipen 150 µg pulver + 0,5 ml sterilt vand |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
PEG-intron redipen 120 µg pulver + 0,5 ml sterilt vand |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
PEG-intron redipen 50 µg pulver + 0,5 ml sterilt vand |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
PEG-intron redipen 80 µg pulver + 0,5 ml sterilt vand |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfa-2b 10 MIE/2 ml injektionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
peginterferon alfa-2b 150 µg pulver + solvens til injektionsvæske, opløsning, fyldt pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
peginterferon alfa-2b 50 µg pulver + solvens til injektionsvæske, opløsning, fyldt pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
peginterferon alfa-2b 80 µg pulver + solvens til injektionsvæske, opløsning, fyldt pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
peginterferon alfa-2b 100 µg pulver + solvens til injektionsvæske, opløsning, fyldt pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
peginterferon alfa-2b 120 µg pulver + solvens til injektionsvæske, opløsning, fyldt pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
peginterferon alfa-2a 180 µg/0,5 ml injektionsvæske, opløsning i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
peginterferon alfa-2a 135 µg/0,5 ml injektionsvæske, opløsning i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon alfa-2a 18 MIE/0,5 ml injektionsvæske, opløsning i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
interferon beta-1b 0,3 mg pulver til injektionsvæske + diluent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Some |
|
injicerbart interferon |
Is a |
False |
Interferon |
Inferred relationship |
Some |
|
Interferon gamma-1b (substance) |
Is a |
False |
Interferon |
Inferred relationship |
Some |
|
Interferon alfa-2a |
Is a |
False |
Interferon |
Inferred relationship |
Some |
|
Interferon alfa-2b |
Is a |
False |
Interferon |
Inferred relationship |
Some |
|
Allergy to interferon |
Causative agent |
False |
Interferon |
Inferred relationship |
Some |
|
Interferon alfacon-1 (substance) |
Is a |
True |
Interferon |
Inferred relationship |
Some |
|
Interferon gamma (substance) |
Is a |
True |
Interferon |
Inferred relationship |
Some |
|
interferon alpha-n1 lymphoblastoid |
Is a |
False |
Interferon |
Inferred relationship |
Some |
|
Interferon alfa-n3 (substance) |
Is a |
False |
Interferon |
Inferred relationship |
Some |
|
Interferon alfa (substance) |
Is a |
True |
Interferon |
Inferred relationship |
Some |
|
Interferon beta (substance) |
Is a |
True |
Interferon |
Inferred relationship |
Some |
|